Logo1
SABM 2008 Annual Meeting
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
Overall quality of the conference.
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Comfort of rooms.
The educational sessions gave a balanced view of therapeutic options, including the use of generic names.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Session was well organized.

Objective 1: Discuss the evidence basis for improving patient safety in multi-disciplinary blood management
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

The presenters were well prepared.

Objective 2: Explain how to promote evidence-based use of blood components and derivatives and pharmacologic options.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

The presenters' teaching abilities were high.

Objective 3: Optimize transfusion practices, including obtaining patient informed consent.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Teaching methods were appropriate.

Objective 4: Compare and contrast the impact of old and new technologies for blood safety.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Utilize patient assessment and treatment tools to enhance their own blood management program.
Facilate change of practice, auditing and tracking of blood utilization to improve blood managementin their own program.
Understand benefits of IV iron.
Give a historical perspective of how we got to where we are now in relationship to patient blood management.
Discuss the risk association between red cell transfusion and morbid outcomes in cardiac surgery.
Examine recent investigations in cardiac surgery as they relate to red cell usage and outcomes.
Examine the role of storage duration in outcomes following cardiac surgery.
List the biological medicines that are currently used as aids for effective hemostasis after surgery, and their specific roles in hemostasis.
Create a higher awareness of blood conservation.
Discuss the background to the evolution of transfusion medicine in Australia.
Explain how cost effectiveness analyses can be applied in transfusion medicine.
Identify recently reported novel functions of the RBC.
Recognize potential adverse outcomes associated with RBC transfusion and how they may relate to newly recognized RBC functions.
Explain the importance of treating change management as a discipline in itself.
Describe current challenges in changing practice to improve patient outcomes.
Summarize evidence for transfusion benefit from randomized controlled trials.
Summarize outcomes associated with transfusion based on observational studies.
Describe the current status of freeze-drying of plasma and its potential use as a resuscitation fluid.
List the numerous freeze-dried platelet-related preparations that have been developed over the years and recount their current status.
Discuss the state of development of the fixed freeze-dried platelet preparations generated in the speaker's laboratory.
Understand the role of the laboratory in assessing platelet function with special reference to the perioperative setting.
Compare the US and Canadian health care systems in general terms.
Discuss the blood management trends that are anticipated to occur in the respective countries in the coming years, including trends anticipated by national blood services with regards to shortages in supply, the development and implementation of anemia clinics and issues involving erythropoietin stimulating agents.
Utilize patient assessment and treatment tools to enhance their own blood management program.
Facilate change of practice, auditing and tracking of blood utilization to improve blood managementin their own program.
Compare the US and Canadian health care systems in general terms.
Discuss the blood management trends that are anticipated to occur in the respective countries in the coming years, including trends anticipated by national blood services with regards to shortages in supply, the development and implementation of anemia clinics and issues involving erythropoietin stimulating agents.
Understand the safety and toxicity of IV iron and the different preparations available.
Understand the potential of IV to reduced transfusions.
Discuss blood transfusion and patient outcomes.
Discuss evidence based blood transfusion.
Review basic principles of fluid management.
Review basic pharmacology of colloids.
Explore evidence for Safety and Efficacy in Colloid Therapy.
Describe the contemporary design of cardioplulmonary bypass circuits as well as the involved components.
Discuss the limits of hemodilution and the affect on oxygen delivery.
Indicate that blood conservation techniques must be practiced collectively with the Cardiac Surgery Team.
Describe the process of initiating an orthopedic clinic.
Identify potential barriers.
Explain educational content and vehicles for marketing.
Develop objectives for presentations.
List three ways of identifying learning needs.
Identify at least four pros and four cons regarding blood transfusions.
Identify essential elements to writing a business proposal.
Design a business plan for implementing a blood management program.
Explain why a business plan is vital to long-term viability and growth of a blood management program.
Identify Physician Champions for your program.
Understand the Implementation process to maintain good Physician Relations.
Explain why Physician Relations play a key role in blood mamagement programs.
Highlight the reasons why there has been a very strong shift towards the use of recombinant clotting factors and other hemostatic agents.
Discuss the potential challenges and prospects for new recombinant hemostatic agents.
Emphasize the important principles in blood conservation.
Demonstrate the success in major operations in different specialties.
List the patient groups for whom erythropoietin is regarded as medically necessary as defined by the ESA coverage determination.
List risks associated with the use of erythropoietin.
Understand anemia of cancer.
Understand implications of the new FDA rules on the use of ESAs in cancer.
Discuss the background to the evolution of patient blood management.
Describe the current structure of the blood supply sector in Australia.
Summarize the current status literature related to the cost of transfusion.
Explain what cost elements are necessary to determine the total cost of transfusion and to conduct cost effectiveness analyses in transfusion medicin
Define methods of communicating current issues in blood management to physicians and other healthcare providers.
Discuss the role of Public Relations in the perception of Blood Management.
List current topics of interest in blood management.
Name a common adverse outcome from long term use of H2 blockers or PPI's.
Identify latent iron deficiency and why it should be addressed in a preoperative assessment.
Identify adjustments that may need to be met in order to use ESA's in 2008.
Explain an organized approach to the management of postpartum hemorrhage.
Discuss the physiologic occurrences in pregnancy that control blood loss at delivery.
List the medical and surgical approaches to the bleeding postpartum patient.

Identify measures used in blood management programs that can support the hospital mission.

Discuss the risk of requiring transfusion and blood conservation strategies in the management of the pediatric patient with parapneumonic effusion.

Discuss the risk of requiring transfusion and blood conservation strategies in the management of the pediatric patient undergoing scoliosis surgery.

Discuss the risk association between red cell transfusion and morbid outcomes in cardiac surgery.
Examine recent investigations in cardiac surgery as they relate to red cell usage and outcomes.
Examine the role of storage duration in outcomes following cardiac surgery.
Review basic principles of fluid management.
Review basic pharmacology of colloids.
Explore evidence for Safety and Efficacy in Colloid Therapy.
Describe the contemporary design of cardioplulmonary bypass circuits as well as the involved components.
Discuss the limits of hemodilution and the affect on oxygen delivery.
Indicate that blood conservation techniques must be practiced collectively with the Cardiac Surgery Team.
Describe the process of initiating an orthopedic clinic.
Identify potential barriers.
Explain educational content and vehicles for marketing.
Develop objectives for presentations.
List three ways of identifying learning needs.
Identify at least four pros and four cons regarding blood transfusions.
Identify essential elements to writing a business proposal.
Design a business plan for implementing a blood management program.
Explain why a business plan is vital to long-term viability and growth of a blood management program.
Identify Physician Champions for your program.
Understand the Implementation process to maintain good Physician Relations.
Explain why Physician Relations play a key role in blood mamagement programs.
Identify key functional and biochemical changes during RBC banking.
Compare, contrast and apply learning from peer driven Blood Management Programs, to initiatives within their organization.
Apply change management steps to initiatives within their organization.
Understand the risk of bleeding associated with clopidogrel exposure and optimal systems for assessing the risk.
Understand the role of treatment algorithms in enhancing blood therapy for platelet disorders.

Cite examples of blood utilization data that can be useful for achieving hospital operational and financial objectives.

Explain the consequences of intractable bleeding in the surgical area.
Summarize the efficacy of the current available hemostatic agents.
Describe the areas of investigation to manage hemostasis.
Objective 5: Implement blood management approaches.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

Was the mode of education effective for learning?

Was the educational content free from commercial bias?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

If you answered “No” to any of the above questions, please explain:

Were you solicited by sales personnel in an educational room while you attended this educational activity?

If you answered “Yes” to the above question, please explain:

What did you learn during this activity that you intend to integrate into your practice?
List any perceived practice “gaps” (educational needs/topics) you would like further trainings focused on:
What barriers might you have that would interfere with implementation of new information from this training?
How can this training be improved to impact your competence or practice?
Are you interested in basic, intermediate or advanced level trainings?
Mr question